Investors Interested In Gushengtang Holdings Limited's (HKG:2273) Earnings
May 13
Hong Kong (HSI) Healthcare Services Industry Analysis
UpdatedMay 19, 2024
DataAggregated Company Financials
Companies57
- 7D1.4%
- 3M11.1%
- 1Y-19.8%
- YTD4.9%
Over the last 7 days, the Healthcare Services industry has risen 1.4%, driven by gains in Sinopharm Group and Guangzhou Baiyunshan Pharmaceutical Holdings of 2.1% and 3.3%, respectively. However, the industry is down 20% over the past year. Earnings are forecast to grow by 19% annually.
Industry Valuation and Performance
Has the Hong Kong Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 19 May 2024 | HK$264.1b | HK$823.2b | HK$12.5b | 12.6x | 21.1x | 0.3x |
| Tue, 16 Apr 2024 | HK$226.1b | HK$820.9b | HK$12.7b | 12.1x | 17.8x | 0.3x |
| Thu, 14 Mar 2024 | HK$246.7b | HK$816.4b | HK$12.7b | 12.9x | 19.5x | 0.3x |
| Sat, 10 Feb 2024 | HK$234.0b | HK$814.9b | HK$12.0b | 14.1x | 19.4x | 0.3x |
| Mon, 08 Jan 2024 | HK$237.1b | HK$819.9b | HK$12.5b | 15.4x | 19x | 0.3x |
| Wed, 06 Dec 2023 | HK$251.1b | HK$820.2b | HK$12.4b | 14.7x | 20.2x | 0.3x |
| Fri, 03 Nov 2023 | HK$251.5b | HK$802.2b | HK$12.2b | 13.7x | 20.6x | 0.3x |
| Sun, 01 Oct 2023 | HK$289.7b | HK$803.8b | HK$12.3b | 12.8x | 23.5x | 0.4x |
| Tue, 29 Aug 2023 | HK$283.1b | HK$782.2b | HK$9.8b | 15.5x | 28.8x | 0.4x |
| Thu, 27 Jul 2023 | HK$340.9b | HK$808.4b | -HK$69,462,085.00 | 11.5x | -4907.5x | 0.4x |
| Sat, 24 Jun 2023 | HK$295.9b | HK$786.9b | HK$653.4m | 10.7x | 452.9x | 0.4x |
| Mon, 22 May 2023 | HK$320.5b | HK$785.0b | HK$981.0m | 11.7x | 326.7x | 0.4x |
| Wed, 19 Apr 2023 | HK$344.8b | HK$802.2b | HK$1.2b | 11.1x | 277.2x | 0.4x |
| Fri, 17 Mar 2023 | HK$326.7b | HK$783.7b | HK$3.7b | 15.8x | 87.5x | 0.4x |
| Sun, 12 Feb 2023 | HK$310.0b | HK$792.8b | HK$3.5b | 15.7x | 89.5x | 0.4x |
| Tue, 10 Jan 2023 | HK$302.8b | HK$791.7b | HK$3.4b | 15.7x | 87.9x | 0.4x |
| Thu, 08 Dec 2022 | HK$286.6b | HK$765.4b | HK$2.9b | 13.8x | 100.2x | 0.4x |
| Sat, 05 Nov 2022 | HK$244.4b | HK$740.9b | HK$1.9b | 12.9x | 131.1x | 0.3x |
| Mon, 03 Oct 2022 | HK$198.3b | HK$667.8b | -HK$2,109,979,584.00 | 14.2x | -94x | 0.3x |
| Wed, 31 Aug 2022 | HK$214.5b | HK$684.2b | -HK$1,688,612,363.00 | 16.8x | -127x | 0.3x |
| Fri, 29 Jul 2022 | HK$234.9b | HK$690.4b | -HK$6,933,217,848.00 | 18.1x | -33.9x | 0.3x |
| Sun, 26 Jun 2022 | HK$234.4b | HK$695.4b | -HK$6,067,123,173.00 | 17.1x | -38.6x | 0.3x |
| Tue, 24 May 2022 | HK$206.2b | HK$694.7b | -HK$6,140,929,326.00 | 16.8x | -33.6x | 0.3x |
| Thu, 21 Apr 2022 | HK$201.2b | HK$714.8b | -HK$7,155,738,187.00 | 17.4x | -28.1x | 0.3x |
| Sat, 19 Mar 2022 | HK$224.8b | HK$718.7b | -HK$4,926,938,672.00 | 15.7x | -45.6x | 0.3x |
| Mon, 14 Feb 2022 | HK$249.8b | HK$716.3b | -HK$5,287,801,551.00 | 16.4x | -47.2x | 0.3x |
| Wed, 12 Jan 2022 | HK$265.8b | HK$713.7b | -HK$5,269,433,509.00 | 18.2x | -50.4x | 0.4x |
| Fri, 10 Dec 2021 | HK$262.3b | HK$714.8b | -HK$5,448,089,223.00 | 17.5x | -48.1x | 0.4x |
| Sun, 07 Nov 2021 | HK$265.0b | HK$708.0b | -HK$5,335,100,347.00 | 16.3x | -49.7x | 0.4x |
| Tue, 05 Oct 2021 | HK$311.5b | HK$692.9b | -HK$5,366,180,365.00 | 16.8x | -58x | 0.4x |
| Thu, 02 Sep 2021 | HK$361.2b | HK$689.6b | -HK$5,408,746,530.02 | 17.6x | -66.8x | 0.5x |
| Sat, 31 Jul 2021 | HK$467.2b | HK$689.6b | -HK$5,408,746,530.02 | 17.9x | -86.4x | 0.7x |
Price to Earnings Ratio
-199.4x
Current Industry PE
- Investors are pessimistic on the Hong Kong Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 21.1x which is higher than its 3-year average PE of -70.9x.
- The industry is trading close to its 3-year average PS ratio of 0.41x.
Past Earnings Growth
- Total earnings for the Healthcare industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 8.3% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 2.56% | |
| Healthcare | -0.91% | |
| Healthcare Services | 1.39% | |
| Healthcare Distributors | 2.36% | |
| Healthcare Services | 0.57% | |
| Healthcare Facilities | 0.055% | |
| Managed Healthcare | 0% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 47.4%, which is higher than its past year's earnings decline of 0.2% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 47% over the next 5 years.
- This is better than its past earnings decline of 0.2% per year.
- In contrast, the Healthcare Distributors industry is expected to see its earnings grow by 7.1% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 1099 Sinopharm Group | HK$21.95 | 2.1% +HK$1.4b | -18.1% | PE7.1x | |
| 874 Guangzhou Baiyunshan Pharmaceutical Holdings | HK$23.55 | 3.3% +HK$1.2b | -7.8% | PE8.6x | |
| 1951 Jinxin Fertility Group | HK$3.18 | 5.0% +HK$413.7m | -27.9% | PE23.6x | |
| 6078 Hygeia Healthcare Holdings | HK$37.45 | 0.9% +HK$221.0m | -26.6% | PE32.1x | |
| 1515 China Resources Medical Holdings | HK$4.42 | 4.0% +HK$220.4m | -33.3% | PE20.6x |
